Skip to main content
. Author manuscript; available in PMC: 2012 Oct 1.
Published in final edited form as: Clin Gastroenterol Hepatol. 2011 Jul 23;9(10):902–909.e1. doi: 10.1016/j.cgh.2011.07.006

Fig. 2.

Fig. 2

(A) Representative hematoxylin and eosin staining of a liver biopsy from a patient with CHC (arrow points to a hepatocyte with a ring-like collection of MDBs). (B) Percentage of patients whose baseline biopsies had MDBs present by levels of fibrosis (3–6), zone 3 pericellular fibrosis (0–2), steatosis (0–4), and inflammation (3–12), p<0.001 for each.